On the contrary, Al-Sudani et al. recently observed the combination of anti-CD47 antibody with PARPi led to significant anti-tumor effects via enhanced in vitro phagocytosis and Sting pathways in BRCA-wild OC patient-derived xenograft model [15]. Here, CD47 is linked to neoplasm.